Glucocorticoids for decompensated heart failure
Referencias
Additional references
Aguirre JA, Ibarra FR, Barontini M, Arrizurieta EE, Armando I. Effect of glucocorticoids on renal dopamine production. European Journal of Pharmacology 1999;370(3):271‐8.
Ashbel' SI, Reznik ND, Vladyko NV. Use of methylprednisolone in patients with circulatory failure. Klinicheskaia Meditsina 1985;63(8):111‐4.
Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. The New England Journal of Medicine2012; Vol. 367, issue 64:2296‐304.
Baylis C, Brenner BM. Mechanism of the glucocorticoid‐induced increase in glomerular filtration rate. The American Journal of Physiology 1978;234(2):F166‐70.
Bayram M, De Luca L, Massie MB, Gheorghiade M. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. The American Journal of Cardiology 2005;96(6A):47G‐58G.
Blecker S, Paul M, Taksler G, Ogedegbe G, Katz S. Heart failure‐associated hospitalizations in the United States. Journal of The American College of Cardiology 2013;61(12):1259‐67.
Braunwald E. Shattuck lecture‐‐cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. The New England Journal of Medicine 1997;337(19):1360‐9.
Bryan PM, Xu X, Dickey DM, Chen Y, Potter LR. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations. The American Journal of Physiology ‐ Renal Physiology 2007;292(5):F1636‐44.
Cohn JN, Franciosa JA, Francis GS, Archibald D, Tristani F, Fletcher R, et al. Effect of short‐term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. The New England Journal of Medicine 1982;306(19):1129‐35.
Cowie MR, Wood DA, Coats AJ, Thompson SG, Suresh V, Poole‐Wilson PA, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart (British Cardiac Society) 2000;83(5):505‐10.
Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS, et al. Short‐term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002;287(12):1541‐7.
Dananberg J, Grekin RJ. Corticoid regulation of atrial natriuretic factor secretion and gene expression. The American Journal of Physiology 1992;263(5 Pt 2):H1377‐81.
de Denus S, Rouleau JL. High‐dose prednisone in patients with heart failure and hyperuricemia: friend and foe?. The Canadian Journal of Cardiology2013; Vol. 29, issue 9:1021‐3.
De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocrine Reviews 1998;19(3):269‐301.
Duru N, van der Goes MC, Jacobs JW, Andrews T, Boers M, Buttgereit F, et al. EULAR evidence‐based and consensus‐based recommendations on the management of medium to high‐dose glucocorticoid therapy in rheumatic diseases. Annals of the Rheumatic Diseases 2013;0:1‐9. [DOI: 10.1136/annrheumdis‐2013‐203249]
Elkayam U, Bitar F, Akhter MW, Khan S, Patrus S, Derakhshani M. Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations. Journal of Cardiovascular Pharmacology and Therapeutics 2004;9(4):227‐41.
Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Annals of Internal Medicine 1985;103(1):1‐6.
Gardner DG, Gertz BJ, Deschepper CF, Kim DY. Gene for the rat atrial natriuretic peptide is regulated by glucocorticoids in vitro. The Journal of Clinical Investigation 1988;82(4):1275‐81.
Hafezi‐Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, et al. Acute cardiovascular protective effects of corticosteroids are mediated by non‐transcriptional activation of endothelial nitric oxide synthase. Nature Medicine 2002;8(5):473‐9.
Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O'Connor CM, Califf RM, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. European Journal of Heart Failure 2007;9(10):1064‐9.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. (accessed in May 2013).
Johnson MJ, Oxberry SG. The management of dyspnoea in chronic heart failure. Current Opinion in Supportive and Palliative Care 2010;4(2):63‐8.
Korochkin IM, Matveeva IV. Hormonal disturbances and the treatment of refractory forms of congestive circulatory insufficiency [Gormonal'nye narusheniia i lechenie bol'nykh s refrakternymi formami zastoinoi zerdechnoi nedostatochnosti]. Kardiologiia 1976;16(8):36‐43.
Labeur M, Holsboer F. Molecular mechanisms of glucocorticoid receptor signaling. Medicina 2010;70(5):457‐62.
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, www.cochrane‐handbook.org (accessed in May 2013).
Liu C, Chen H, Zhou C, Ji Z, Liu G, Gao Y, et al. Potent potentiating diuretic effects of prednisone in congestive heart failure. Journal of Cardiovascular Pharmacology 2006;48(4):173‐6.
Liu C, Liu G, Zhou C, Ji Z, Zhen Y, Liu K. Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance. Canadian Journal of Cardiology 2007;23(11):865‐8.
Liu C, Guan J, Kang Y, Xiu H, Chen Y, Deng B, et al. Inhibition of dehydration‐induced water intake by glucocorticoids is associated with activation of hypothalamic natriuretic peptide receptor‐A in rat. PloS One 2010;5(12):e15607.
Liu C, Chen Y, Kang Y, Ni Z, Xiu H, Guan J, et al. Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up‐regulating natriuretic peptide receptor‐A expression in the renal inner medullary collecting duct in decompensated heart failure. Journal of Pharmacology and Experimental Therapeutics 2011;339(1):203‐9.
Liu C, Zhao Q, Zhen Y, Gao Y, Tian L, Wang L, et al. Prednisone in uric acid lowering in symptomatic heart failure patients with hyperuricemia (PUSH‐PATH) Study. Canadian Journal of Cardiology 2013;29(9):1048‐54.
MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000;102(10):1126‐31.
Maeder MT, Rickli H, Pfisterer ME, Muzzarelli S, Ammann P, Fehr T, et al. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. American Heart Journal 2012;163(3):407‐14.
Massari F, Mastropasqua F, Iacoviello M, Nuzzolese V, Torres D, Parrinello G. The glucocorticoid in acute decompensated heart failure: Dr Jekyll or Mr Hyde?. American Journal of Emergency Medicine 2012;30(3):517.e5‐10.
May CN, Bednarik JA. Regional hemodynamic and endocrine effects of aldosterone and cortisol in conscious sheep. Comparison with the effects of corticotropin. Hypertension 1995;26(2):294‐300.
McKelvie RS, Moe GW, Ezekowitz JA, Heckman GA, Costigan J, Ducharme A, et al. The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. Canadian Journal of Cardiology 2013;29(2):168‐81.
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure 2012;14(8):803‐69.
Mickerson JN, Swale J. Diuretic effect of steroid therapy in obstinate heart failure. British Medical Journal 1959;1(5126):876‐83.
Newman DA. Reversal of intractable cardiac edema with prednisone. New York State Journal of Medicine 1959;59(4):625‐33.
Nishimura H, Yoshikawa T, Kobayashi N, Anzai T, Nagami K, Handa S, et al. Effects of methylprednisolone on hemodynamics and beta‐adrenergic receptor signaling in rabbits with acute left ventricular failure. Heart and Vessels 1997;12(2):84‐91.
O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, et al. Effect of nesiritide in patients with acute decompensated heart failure. The New England Journal of Medicine 2011;365(1):32‐43.
Potter LR, Abbey‐Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate‐dependent signaling functions. Endocrine Reviews 2006;27(1):47‐72.
Rado JP, Blumenfeld G, Hammer S. The effect of prednisone and 6‐methylprednisolone on mercurial diuresis in patients with refractory cardiac edema. The American Journal of the Medical Sciences 1959;238:542‐51.
Ribeiro RA, Rohde LE, Polanczyk CA. Levosimendan in acute decompensated heart failure: systematic review and meta‐analysis. Arquivos Brasileiros De Cardiologia 2010;95(2):230‐7.
Riemer AD. Application of the newer corticosteroids to augment diuresis in congestive heart failure. The American Journal of Cardiology 1958;1(4):488‐96.
Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. The New England Journal of Medicine 1999;341(8):577‐85.
Shanoff HM. Diuretics in cardiac edema‐‐1969. Canadian Medical Association Journal 1969;101(7):66‐70.
Tacon CL, McCaffrey J, Delaney A. Dobutamine for patients with severe heart failure: a systematic review and meta‐analysis of randomised controlled trials. Intensive Care Medicine 2012;38(3):359‐67.
Whitworth JA, Gordon D, Andrews J, Scoggins BA. The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume. Journal of Hypertension 1989;7(7):537‐49.
